Despite the uncertain economic environment, Russia still represents a promising health care market with strong potential for further growth. The growth will be primarily driven by strong governmental support, which aims at reversing the gloomy state of the Russian health care system and deteriorating demographic situation. The positive market outlook is also based on the expectation that the incomes of an increasingly health-conscious Russian population will resume an upward trend.
A new analysis from Frost & Sullivan ( http://www.medicaldevices.frost.com), Overview of Pharmaceutical and Medical Devices Industry in Russia and CIS, finds that, despite a tumultuous 2009, the Russian health care markets will continue exhibiting respectable growth rates. Having shrunk by 6% in US dollar-terms, the pharmaceutical market has grown at 28% in roubles, while the medical devices market has expanded at 4%-5%. In the forecast period 2009-2013, both segments will grow at above world average rates, explained by under-satisfied home demand for healthcare goods and services.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
| Headless Content Management with Blaze